Cost-Effectiveness of Saxagliptin in Type 2 Diabetes in the United States

被引：0
作者：
Bergenheim, Klas
Williams, Setareh A.
Bergeson, Joette G.
Stern, Lee
Sriprasert, Michelle
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2369-PO
引用
收藏
页码：A629 / A630
页数：2
相关论文
共 50 条
[41]   DRIVERS OF COST-EFFECTIVENESS IN TYPE-2 DIABETES MELLITUS [J].
McEwan, P. ;
Foos, V ;
Grant, D. ;
Lamotte, M. ;
Palmer, J. L. ;
Lloyd, A. .
VALUE IN HEALTH, 2013, 16 (03) :A165-A165
[42]   Cost-effectiveness issues in type 2 diabetes prevention in the USA [J].
Palmer, AJ ;
Roze, S .
DIABETES, 2002, 51 :A279-A279
[43]   Cost-effectiveness of a lifestyle intervention in preventing Type 2 diabetes [J].
Irvine, Lisa ;
Barton, Garry R. ;
Gasper, Amy V. ;
Murray, Nikki ;
Clark, Allan ;
Scarpello, Tracey ;
Sampson, Mike .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2011, 27 (04) :275-282
[44]   Cost-Effectiveness of Aliskiren in Type 2 Diabetes, Hypertension, and Albuminuria [J].
Delea, Thomas E. ;
Sofrygin, Oleg ;
Palmer, James L. ;
Lau, Helen ;
Munk, Veronica C. ;
Sung, Jennifer ;
Charney, Alan ;
Parving, Hans-Henrik ;
Sullivan, Sean D. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (10) :2205-2213
[45]   Assessment of the cost-effectiveness of influenza vaccination for type 2 diabetes [J].
Sorensen, S ;
Gibbons, C ;
Engelgau, M ;
Narayan, KMV ;
Hoerger, T ;
Valdez, R ;
Gregg, E ;
Thompson, T ;
Bethke, A .
DIABETES, 2003, 52 :A11-A11
[46]   Self-monitoring of blood glucose in type 2 diabetes: Cost, effectiveness in the United States [J].
Tunis, Sandra L. ;
Minshall, Michael E. .
AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (03) :131-140
[47]   COST-EFFECTIVENESS ANALYSES OF TYPE 2 DIABETES MELLITUS TREATMENTS PUBLISHED IN THE UNITED STATES: A SYSTEMATIC LITERATURE REVIEW OF RESULTS AND QUALITY ASSESSMENT [J].
Garg, V ;
Raisch, D. W. ;
Borrego, M. .
VALUE IN HEALTH, 2012, 15 (04) :A181-A181
[48]   Cost-effectiveness of finerenone added to standard of care for patients with type 2 diabetes-related chronic kidney disease in the United States [J].
Zheng, Cailin ;
Wu, Jinneng ;
Li, Na ;
Wei, Xiaoxia ;
Huang, Zhixiong ;
Chen, Lingbin ;
Chen, Zhou .
DIABETES OBESITY & METABOLISM, 2025, 27 (01) :165-173
[49]   Cost-effectiveness analysis of empagliflozin versus sitagliptin as second-line therapy for treatment in patients with type 2 diabetes in the United States [J].
Reifsnider, Odette ;
Kansal, Anuraag ;
Pimple, Pratik ;
Aponte-Ribero, Valerie ;
Brand, Sarah ;
Shetty, Sharash .
DIABETES OBESITY & METABOLISM, 2021, 23 (03) :791-799
[50]   Short-term cost-effectiveness of tirzepatide for the treatment of type 2 diabetes in the United States (vol 29, pg 276, 2023) [J].
Zhang, Z. ;
Marx, C. McAdam .
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (06) :714-714
12345